Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001241073 | SCV001414063 | uncertain significance | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 1901 of the PCDH15 protein (p.Ser1901Gly). This variant is present in population databases (rs763251067, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with PCDH15-related conditions. ClinVar contains an entry for this variant (Variation ID: 966407). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001834139 | SCV002075898 | uncertain significance | Usher syndrome type 1F | 2020-04-13 | no assertion criteria provided | clinical testing | |
Institute of Human Genetics, |
RCV004813983 | SCV005071869 | uncertain significance | Retinal dystrophy | 2023-01-01 | no assertion criteria provided | clinical testing |